Methylene blue vs NAD⁺ precursors
Two approaches to mitochondrial energy with very different risk profiles: an approved drug repackaged as a biohack, versus a supplement that reliably moves a biomarker and nothing more.
Methylene blue
An FDA-approved drug (for methemoglobinemia) with a single-dose human memory/fMRI signal and a plausible low-dose mitochondrial mechanism — but longevity claims are preclinical and it risks serotonin syndrome with antidepressants.
Full Methylene blue evidence reviewNAD⁺ precursors
NR / NMN
Oral NR/NMN reliably raise blood NAD⁺ in RCTs — but whether that translates into anti-aging outcomes is still open.
Full NAD⁺ precursors evidence reviewSide by side
| Methylene blue | NAD⁺ precursors | |
|---|---|---|
| Marketed for | Mitochondrial energy, nootropic, anti-aging | Cellular energy, anti-aging |
| Evidence grade | Clinical data | Clinical data |
| Family | NAD⁺ & mitochondrial | NAD⁺ & mitochondrial |
| Key human source | fMRI RCT, Radiology 2016 | NR PK RCT, Nat Commun 2016 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
Methylene blue is a genuine drug, FDA-approved for methemoglobinemia rather than aging, with a plausible low-dose electron-carrier mechanism and one randomized single-dose brain-imaging study linking it to improved memory retrieval; its anti-aging claims are preclinical only. It also has a hormetic dose-response where high doses flip to pro-oxidant, and as a potent MAO-A inhibitor it can trigger potentially fatal serotonin syndrome with SSRIs, SNRIs or other serotonergic drugs, a documented interaction rather than a theoretical one. NAD+ precursors carry none of that: they raise blood NAD+ in randomized trials, look safe short-term, and likewise show no healthspan benefit. The two have not been compared directly.
Methylene blue fits if
Nobody should approach this as a supplement; if it is considered at all it belongs in a conversation with a clinician, and it is simply off the table for anyone on a serotonergic antidepressant.
NAD⁺ precursors fits if
Someone who wants the mitochondrial-energy idea without a drug's interaction profile, accepting that raising NAD+ is exactly where the evidence stops.
Where to get it
Where to get NAD⁺ therapy
Telehealth services offering NAD⁺ as oral precursors, prescription injections, or clinic IV drips. Formats and pricing vary — confirm current NAD⁺ (NR & NMN) options with the provider.
